Who owns Neurocrine Biosciences?

Key details on Neurocrine Biosciences (Ticker: NBIX)

Who owns Neurocrine Biosciences?

Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.

Fund Name Number of Shares Share Valuation As Of
FMR 12.88M $512.53M Sept. 30, 2015
T. Rowe Price Associates 8.77M $348.96M Sept. 30, 2015
BVF 5.93M $50.40M Dec. 31, 2011
Vanguard 5.76M $229.34M Sept. 30, 2015
OrbiMed Advisors 3.82M $151.84M Sept. 30, 2015
BlackRock Fund Advisors 3.34M $133.01M Sept. 30, 2015
BB Biotech AG 3.17M $126.20M Sept. 30, 2015
Perceptive Advisors 2.94M $117.10M Sept. 30, 2015
PointState Capital 2.63M $104.57M March 31, 2015
Westfield Capital Management Company 2.29M $90.87M March 31, 2015
VHCP Management 2.22M $16.62M Dec. 31, 2012
Franklin Resources 2.20M $32.71M June 30, 2014
Visium Asset Management 2.20M $87.52M Sept. 30, 2015
Inves 2.18M $86.91M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 2.02M $96.67M June 30, 2015
STATE STREET CORPORATION 2.02M $80.35M Sept. 30, 2015

Who sold Neurocrine Biosciences?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wellington Management Company Dec. 31, 2010 2.17M $16.59M